Example: Heart Attack

Clinical Trials Sponsored by Boehringer Ingelheim

Total 2415 results

NCT05891275

Not yet recruiting

Patients With Geographic Atrophy and Their Patient Journey in the United States (US)

Geographic Atrophy
NCT05882058

Not yet recruiting

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

Small Cell Lung Carcinoma | Neuroendocrine Neoplasms
NCT05882071

Not yet recruiting

Non-interventional Study (NIS) on Sodium-glucose Co-transporter-2 Inhibitors (SGLT2i) Use in France

Diabetes Mellitus, Type 2
NCT05879978

Not yet recruiting

A Study to Test How Well Different Doses of BI 764532 in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3

Neuroendocrine Neoplasms | Small Cell Lung Carcinoma (SCLC)
NCT05879991

Not yet recruiting

A Study in Healthy Men to Test How BI 1810631 is Taken up and Processed by the Body

Healthy
NCT05870956

Not yet recruiting

Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) Patients

Idiopathic Pulmonary Fibrosis
NCT05865886

Not yet recruiting

A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™)

Bronchiectasis | Cystic Fibrosis
NCT05863130

Recruiting

A Study in Healthy Men to Test How BI 764198 is Processed in the Body

Healthy
NCT05857878

Not yet recruiting

A Study to Test How Well Different Doses of BI 1815368 Are Tolerated by Healthy Men

Healthy
NCT05856526

Recruiting

A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome

Netherton Syndrome
NCT05855109

Not yet recruiting

Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors

Arthritis, Rheumatoid | Lung Diseases, Interstitial
NCT05846230

Not yet recruiting

ClairleafTM: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine

Bronchiectasis
NCT05846516

Recruiting

A Study to Evaluate ATP150/ATP152, VSV-GP154 and Ezabenlimab in Patients With KRAS G12D/G12V Mutated PDAC (KISIMA-02)

Pancreatic Ductal Adenocarcinoma
NCT05839600

Recruiting

A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer

Solid Tumors
NCT05838625

Recruiting

Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia (CONVOKE)

Schizophrenia
NCT05826756

Recruiting

Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting (PEER)

Caregivers | Lung Cancer Patients
NCT05819398

Recruiting

Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

Hidradenitis Suppurativa
NCT05819385

Not yet recruiting

Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) Epidemiology Non-interventional Study (NIS)

Lung Diseases, Interstitial
NCT05799755

Not yet recruiting

Myositis Interstitial Lung Disease Nintedanib Trial (MINT)

Myositis Associated Interstitial Lund Disease (MA-ILD)
NCT05786443

Not yet recruiting

Safety and Efficacy of Empagliflozin in Hemodialysis (SEED)

End Stage Renal Disease
NCT05781334

Not yet recruiting

Optimizing In-hospital Use of Evidence-based Therapies for Patients With Cardio-Renal-Metabolic Disease (IMPLEMENT-CRM)

Heart Failure | Chronic Kidney Diseases | Type 2 Diabetes
NCT05751226

Recruiting

A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906

Healthy | Obesity
NCT05741372

Recruiting

A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

Liver Cirrhosis
NCT05741385

Recruiting

A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

Liver Cirrhosis
NCT05738291

Recruiting

A Study in Healthy Men to Test How Well Multiple Doses of BI 1839100 Are Tolerated

Healthy
NCT05734690

Recruiting

COPILOT-HF: Cooperative Program for ImpLementation of Optimal Therapy in Heart Failure (COPILOT-HF)

Heart Failure
NCT05731895

Recruiting

A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Liver Problems

Hepatic Insufficiency
NCT05728489

Recruiting

A Study to Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque Psoriasis

Psoriasis
NCT05718648

Recruiting

A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Kidney Problems

Healthy | Renal Insufficiency
NCT05718843

Recruiting

A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Kidney Problems

Renal Insufficiency
NCT05708599

Recruiting

A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer

Colorectal Cancer | Pancreatic Ductal Adenocarcinoma | Non-Small-Cell Lung Carcinoma
NCT05701176

Recruiting

A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer (SHARP)

Advanced Stage Non-small Cell Lung Cancer
NCT05676112

Not yet recruiting

Safety of Nintedanib in Real World in China

Pulmonary Fibrosis
NCT05671991

Recruiting

Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease (EMPA-PD)

End Stage Renal Disease on Dialysis
NCT05670821

Not yet recruiting

PMS of Spesolimab I.V. in GPP Patients With Acute Symptoms

Generalized Pustular Psoriasis

Clinical Trials Sponsored by Boehringer Ingelheim

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations